Navigation Links
India's anti-AIDS drug market engaged in price war

The Indian pharmaceutical companies hope to strike a pot of gold by making cheap anti-AIDS drugs. This has triggered a price war that is likely to escalate in coming days.

The large number of AIDS cases has lured many companies to develop anti-AIDS drugs and market it in India and abroad by adapting innovative approaches to pricing.

The anti-AIDS drug market, currently dominated by Mumbai-based Cipla, witnessed the entry of four more pharmaceutical companies including Ranbaxy laboratories, GlaxoSmithKline Pharmaceuticals, Aurobindo Pharmaceuticals and Zydus Cadila in a short span of six months to one year.

The rising competition in the domestic anti-AIDS drug market has led to Cipla, a leader in the segment, cut its brand prices five to six times in the last three years. Thus, Cipla triggered a controversy by offering anti-AIDS drugs at a drastically lower prices.

Pharmaceutical companies in India are able to gain good healthy revenues, even if these anti-AIDS drugs are sold at steep discounts. India's patent laws currently protect only the processes by which drugs are made but not the products themselves.
'"/>




Page: 1

Related medicine news :

1. SARS: Indias drugs in demand
2. Indias Hospitals Among The Best, Says Renuka Chowdhury
3. Indias vaccination project gets a boost
4. WHO Commends Indias Bird Flu Response
5. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
6. Indias Economic Boom Pack To Waste Children Life
7. Indias Northeast Students to Get Satellite-based Education Soon
8. Norway Grants $80 mn to Indias Health Mission
9. Pakistani Child is Indias Youngest Liver Transplant Recipient
10. Avian flu-free Status to Boost Indias Poultry Exports
11. Britains Support for Indias Health Programme
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... Yes, the Millennials love their Bluetooth ... Council on Active Aging® (ICAA), new tech is also finding a home in senior ... , queried respondents from a variety of organizations that work with older adults about ...
(Date:1/14/2019)... ... 14, 2019 , ... Trees can be overweight too! Giroud Tree and ... and winter is a great time to clean things up on the property! , ... damage, especially during windy or icy storms. The crown of the tree should be ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, ... Temple University hosted a continuing education (CEU) event entitled, Can You Hear Me ... to create a series of talks to help develop and cultivate the relationship ...
(Date:1/11/2019)... ... January 11, 2019 , ... Ms. ... training in the U.S., alleges that Andrews and others engaged in a systematic ... Andrews disparagingly referred to employees by race and by the color of their ...
(Date:1/10/2019)... ... January 10, 2019 , ... Net-Translators, an ... with MD101, a regulatory consulting company that serves the medical industry. The companies ... companies in the medical device and healthcare industries. Based in France, they join ...
Breaking Medicine News(10 mins):
(Date:1/21/2019)... ... January 21, 2019 , ... With more than 10,000 ... the growth needs of our clients with prompt, effective and cost-efficient installation services of ... operating in four states in the U.S. and two provinces in Canada with additional ...
(Date:1/21/2019)... ... January 21, 2019 , ... Nanomedical ... corporate name change to Cardea , effective January 21, 2019. , The ... serving the pharmaceutical industry with ultra sensitive biosensor research tools, to opening its ...
(Date:1/20/2019)... ... January 18, 2019 , ... The Icahn School of ... drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company ... , MPS is a group of 11 lysosomal storage diseases, metabolic disorders caused ...
Breaking Medicine Technology: